Clinical Trial Update: Nebivolol Versus Sustained Release Metoprolol Succinate in Patients With Chronic Kidney Disease

View source ↗

Summary

This completed trial compares nebivolol with sustained-release metoprolol succinate in adults with chronic kidney disease to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Metoprolol succinate (sustained-release) (metoprolol succinate)
• Nebivolol (Nebivolol)

Snippet

Sponsor: University of Michigan | Conditions: Chronic Kidney Disease | Status: COMPLETED